Positron emission tomography: Present and future

Technology and Health Care

Volumn 4, Issue 1, 1996, Pages 15-29

  Heiss, W D ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TUMOR; DEMENTIA; EPILEPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0030497774     PISSN: 09287329     EISSN: None     Source Type: Journal    
DOI: 10.3233/thc-1996-4104     Document Type: Review

References (60)

1. J.B. Alavi, A. Alavi, J. Chawluk, M. Kushner, J. Powe, W. Mickey and M. Reivich, Positron emission tomography in patients with glioma. A predictor of prognosis, Cancer. 62 (1988), 1074-1078.
2. J.C. Baron, M.G. Bousser, A. Rey, A. Guillard, D. Comar and P. Castaigne, Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia, Stroke 12 (1981), 454-459.
3. 11C-L-methionine, J. Neurooncology 3 (1986), 397-404.
4. S.R. Cherry, M. Dahlbom and E.J. Hoffman, 3D PET using a conventional multislice tomograph without septa, J. Comput. Assist. Tomogr. 15 (1991), 655-668.
5. F. Chollet, V. DiPiero, R.J.S. Wise, D.J. Brooks, R.J. Dolan and R.S.J. Frackowiak, The functional anatomy of motor recovery after stroke in humans: A study with positron emission tomography, Ann. Neurol. 29 (1991), 63-71.
6. T.H. Crook III, Diagnosis and treatment of normal and pathologic memory impairment in later life, Sem. Neurology 9 (1989), 20-30.
7. 18F)-fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool, Invest. Radiology 22 (1987), 360-371.
8. J.E. Dominguez, J.F. Graham, C.J. Gummins et al., Enzymes of glucose metabolism in cultured human gliomas: neoplasia is accompanied by altered hexokinase, phosphofructokinase, and glucose-6-phosphate dehydrogenase levels, Metabol. Brain Dis. 2 (1987), 17-30.
9. 18F)-FDG and Rb-82 PET, J. Comput. Assist. Tomogr. 11 (1987), 563-570.
10. K. Ericson, G. Blomqvist, M. Bergström, L. Eriksson and S. Stone Elander, Application of a kinetic model on the methionine accumulation in intracranial tumors studied with positron emission tomography, Acta Radiol. 28 (1987), 505-509.
11. D.M. Feeney and J.C. Baron, Diaschisis, Stroke 17 (1986), 817-830.
12. G.R. Fink, K. Herholz, U. Pietrzyk, M. Huber and W.-D. Heiss, Peri-infarct perfusion in human ischemia: Its relation to tissue metabolism, morphology, and clinical outcome, J. Stroke Cerebrovasc. Dis. 3 (1993), 123-131.
13. R.S.J. Frackowiak, Functional mapping of verbal memory and language, TINS 17 (1994), 109-115.
14. G. Franck, P. Maquet, B. Sadzot, E. Salmon, R. Debets, D. Dive, T. Grisar, D. Guillaume, C. Van Veelen et al., Contribution of positron emission tomography to the investigation of epilepsies of frontal lobe origin, in: Advances in Neurology, P. Chauvel, A.F. Delgado-Escueta et al., eds, Raven Press, Ltd., New York, 1992, pp. 471-485.
15. K.J. Friston, C.D. Frith, P.F. Liddle and R.S.J. Frackowiak, Functional connectivity: The principal-component analysis of large (PET) data sets, J. Cereb. Blood Flow Metab. 13 (1993), 5-14.
16. A. Gjedde, K. Wienhard, W.-D. Heiss, G. Kloster, N.H. Diemer, K. Herholz and G. Pawlik, Comparative regional analysis of 2-fluoro-deoxy-glucose and methyl-glucose uptake in brain of four stroke patients. With special reference to the regional estimation of the lumped constant, J. Cereb. Blood Flow Metab. 5 (1985), 163-178.
17. A.M. Hakim, A.C. Evans, L. Berger, H. Kuwabara, K. Worsley, G. Marchal, C. Beil, R. Pokrupa et al., The effect of nimodipine on the evolution of human cerebral infarction studied by PET, J. Cereb. Blood Flow Metab. 9 (1989), 523-534.
18. W.-D. Heiss and K. Herholz, Assessment of pathophysiology of stroke by positron emission tomography, Eur. J. Nucl. Med. 21 (1994), 455-465.
19. W.-D. Heiss, V. Holthoff, G. Pawlik and M. Neveling, Effect of nimodipine on regional cerebral glucose metabolism in patients with acute ischemic stroke as measured by positron emission tomography, J. Cereb. Blood Flow Metab. 10 (1990), 127-132.
20. W.-D. Heiss, M. Huber, G. Fink, K. Herholz, U. Pietrzyk, R. Wagner and K. Wienhard, Progressive derangement of periinfarct viable tissue in ischemic stroke, J. Cereb. Blood Flow Metab. 12 (1992), 193-203.
21. W.-D. Heiss, J. Kessler, H. Karbe, G.R. Fink and G. Pawlik, Cerebral glucose metabolism as a predictor of recovery from aphasia in ischemic stroke, Arch. Neurol. 50 (1993), 958-964.
22. W.-D. Heiss, B. Szelies, J. Kessler and K. Herholz, Abnormalities of energy metabolism in Alzheimer's disease studied with PET, Ann. NY Acad. Sci. 640 (1991), 65-71.
23. T.R. Henry, J. Engel and J.C. Mazziotta, Clinical evaluation of interictal fluorine-18-fluoro-deoxy-glucose PET in partial epilepsy, J. Nucl. Med. 34 (1993), 1892-1898.
24. K. Herholz, R. Adams, J. Kessler, B. Szelies, M. Grond and W.-D. Heiss, Criteria for the diagnosis of Alzheimer's disease with positron emission tomography, Dementia 1 (1990), 156-164.
25. K. Herholz, B. Friedrichs, J. Jeske and W.-D. Heiss, Prognostic significance of positron emission tomography with F-18-fluoro-deoxy-glucose in gliomas, J. Cancer Res. Clin. Oncol. 118 (Suppl.) (1992) R119.
26. K. Herholz, U. Pietrzyk, J. Voges, R. Schröder, M. Halber, H. Treuer, V. Sturm and W.-D. Heiss, Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study, J. Neurosurg. 79 (1993), 853-858.
27. K. Herholz, P. Ziffling, W. Staffen, G. Pawlik, R. Wagner, K. Wienhard and W.-D. Heiss, Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET, Eur. J. Cancer Clin. Oncol. 24 (1988), 1139-1150.
28. T. Hölzer, K. Herholz, J. Jeske and W.-D. Heiss, FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma, J. Comput. Assist. Tomogr. 17 (1993), 681-687.
29. M. Huber, B. Kittner, C. Hojer, G.R. Fink, M. Neveling and W.-D. Heiss, Effect of propentofylline on regional cerebral glucose metabolism in acute ischemic stroke, J. Cereb. Blood Flow Metab. 13 (1993), 526-530.
30. J. Kessler, M. Ghaemi, R. Mielke, K. Herholz and W.-D. Heiss, Visual versus auditory memory stimulation in patients with probable Alzheimer's disease: A PET study with 18-FDG, in: The Neurobiology of Alzheimer's Disease, J.H. Growdon, R.M. Nitsch, S. Corkin and R.J. Wurtman, eds, Center for Brain Sciences and Metabolism Charitable Trust, Cambridge, USA, 1995, pp. 275-280.
31. 11C-L-methionine accumulation in brain tumors with positron emission tomography, J. Nucl. Med. 28 (1987), 645.
32. N.A. Lassen, D.H. Ingvar, M.E. Raichle and L. Friberg, Brain Work and Mental Activity, Munksgaard, Copenhagen, 1991.
33. K.D. Laxer and P.A. Garcia, Imaging criteria to identify the epileptic focus, Epilepsy Surgery 4 (1993), 199-209.
34. M. Levivier, S. Goldman, L.M. Bidaut, A. Luxen, E. Stanus, S. Przedborski, D. Balériaux, J. Hildebrand and J. Brotchi, Positron emission tomography-guided stereotactic brain biopsy, Neurosurgery 31 (1992), 792-797.
35. O.H. Lowry, S.J. Berger, J.G. Carter et al., Diversity of metabolic patterns in human brain tumors: Enzymes of energy metabolism and related metabolites and cofactors, J. Neurochem. 41 (1983), 994-1010.
36. G. Marchal, C. Serrati, P. Rioux, M.C. Petit-Taboué, F. Viader, V. de la Sayette, F. le Doze, P. Lochon et al., PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome, Lancet 341 (1993), 925-927.
37. J.C. Mazziotta, M.E. Phelps, J.J. Pahl, S.-C. Huang, L.R. Baxter, W.H. Riege et al., Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease, New Engl. J. Med. 316 (1987), 357-362.
38. J.C. Mazziotta, D. Valentino, S. Grafton, F. Bookstein, C. Pelizzari, G. Chen and A.W. Toga, Relating structure to function in vivo with tomographic imaging, Ciba Foundation Symposium 163 (1991), 93-112.
39. C.S. Patlak, R.G. Blasberg and J.D. Fenstermacher, Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data, J. Cereb. Blood Flow Metab. 3 (1983), 1-7.
40. N.J. Patronas, G. DiChiro, C. Kufta, D. Bairamian, P.L. Kornblith, R. Simon and S.M. Larson, Prediction of survival in glioma patients by means of positron emission tomography, J. Neurosurg. 62 (1985), 816-822.
41. G. Pawlik, G.R. Fink, J. Kessler and W.-D. Heiss, PET and functional testing in temporal lobe epilepsy, Acta Neurol. Scand. (Suppl.) 152 (1994), 150-156.
42. C.A. Pelizzari, G.T.Y. Chen, H. Halpern, C.T. Chen and M.D. Cooper, Three-dimensional correlation of PET, CT and MRI images, J. Nucl. Med. 28 (1987), 682.
43. U. Pietrzyk, K. Herholz, G. Fink, A. Jacobs, R. Mielke, I. Slansky, M. Würker and W-D. Heiss, An interactive technique for three-dimensional image registration: Validation for PET, SPECT, MRI and CT brain studies, J. Nucl. Med. 35 (1994), 2011-2018.
44. U. Pietrzyk, K. Herholz and W.-D. Heiss, Three-dimensional alignment of functional and morphological tomograms, J. Comput. Assist. Tomogr. 14 (1990), 51-59.
45. W.J. Powers, R.L. Grubb, Jr., D. Darriet and M.E. Raichle, Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans, J. Cereb. Blood Flow Metab. 5 (1985), 600-608.
46. M.E. Raichle, Studies of the processing of single words in normal human subjects with PET, in: Brain Work and Mental Activity, N.A. Lassen, D.H. Ingvar, M.E. Raichle and L. Friberg, eds, Munksgaard, Copenhagen, 1991, pp. 315-321.
47. M.E. Raichle, Images of the mind: Studies with modern imaging techniques, Annu. Rev. Psychol. 45 (1994), 333-356.
48. S.I. Rapoport, Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: A critical review, Cerebrovasc. Brain Metab. Rev. 3 (1991), 297-335.
49. M. Reivich, Crossed cerebellar diaschisis, Am. J. Neuroradiol. 13 (1992), 62-64.
50. 18F)-FDG as PET markers of epileptic foci, J. Neurol. Neurosurg. Psychiatry 56 (1993), 615-621.
51. 11C-L-methionine PET, J. Nucl. Med. 27 (1986), 890-891.
52. B.E. Swartz, U. Tomiyasu, A.V. Delgado-Escueta, M. Mandelkern and A. Khonsari, Neuroimaging in temporal lobe epilepsy: Test sensitivity and relationships to pathology and postoperative outcome, Epilepsia 33 (1992), 624-634.
53. W.H. Theodore, MRI, PET, SPECT: interrelations, technical limits, and unanswered questions, in: Surgical Treatment of Epilepsy, W.H. Theodore, ed., Elsevier Science Publ. BV, Amsterdam, 1992, pp. 127-134.
54. D.H. Townsend, A. Geissbuhler, M. Defrise, E.J. Hoffman, T.R. Spinks, D.L. Bailey, M.C. Gilardi and T. Jones, Fully three-dimensional reconstruction for a PET camera with retractable septa, IEEE Trans. Med. Imaging 10 (1991), 505-512.
55. J.L. Tyler, M. Diksic, J.G. Villemure, A.C. Evans, E. Meyer, Y.L. Yamamoto and W. Feindel, Metabolic and hemodynamic evaluation of gliomas using positron emission tomography, J. Nucl. Med. 28 (1987), 1123-1133.
56. O. Warburg, On the origin of cancer cells, Science 123 (1956), 309-314.
57. J. Watson and S. Grootoonk, ECAT Technical User's Meeting, Cologne, Germany, March 29-30, 1993.
58. K. Wienhard, M. Dahlbom, L. Eriksson, Ch. Michel, T. Bruckbauer, U. Pietrzyk and W.-D. Heiss, The ECAT EXACT HR: Performance of a new high resolution positron scanner, J. Comput. Assist. Tomogr. 18 (1994), 110-118.
59. 18F)fluoro-tyrosine, J. Nucl. Med. 32 (1991), 1338-1346.
60. R.J.S. Wise, S. Bernardi, R.S.J. Frackowiak, N.J. Legg and T. Jones, Serial observations on the pathophysiology of acute stroke, Brain 106 (1983), 197-222.